Certificate Under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Welcure Drugs & Pharmaceuticals has submitted a routine compliance certificate to BSE for the quarter ended June 30, 2025. The certificate, issued by its Registrar and Transfer Agent Skyline Financial Services Pvt Ltd, confirms that physical share certificates received for demat have been verified, the underlying securities are listed on the stock exchange, and the original certificates were cancelled and replaced with the depository's name as the registered owner within the 15-day SEBI deadline. This is a standard quarterly filing mandated under SEBI's Depository Participant Regulations and involves no new corporate action or business update.
No material impact on shareholders or stock price — this is a routine procedural filing confirming that physical-to-demat share conversions were processed on time.